DYADIC INTERNATIONAL INC Income Tax Expense
DYADIC INTERNATIONAL INC (DYAI) reported Income Tax Expense of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-12
- DYADIC INTERNATIONAL INC income tax expense (benefit) for the quarter ending 2026-06-30 was $0.00.
- DYADIC INTERNATIONAL INC income tax expense (benefit) for the quarter ending 2026-03-31 was $0.00.
- DYADIC INTERNATIONAL INC income tax expense (benefit) for the quarter ending 2020-12-31 was $31.32K, a 232.96% increase year-over-year.
- DYADIC INTERNATIONAL INC income tax expense (benefit) for the quarter ending 2020-09-30 was $0.00.
- DYADIC INTERNATIONAL INC income tax expense (benefit) for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- DYADIC INTERNATIONAL INC income tax expense (benefit) for fiscal 2020 was $31.32K, a 203.88% increase from fiscal 2019.
- DYADIC INTERNATIONAL INC income tax expense (benefit) for fiscal 2019 was $10.31K.
- DYADIC INTERNATIONAL INC income tax expense (benefit) for fiscal 2018 was -$1.01M.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | |||
| 2021-12-31 | $0.00 10-K · filed 2022-03-29 | |||
| 2020-12-31 | $31.32K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $31.32K derived: sum of 2 quarters · filed 2022-03-29 | $31.32K derived: sum of 3 quarters · filed 2022-03-29 | $31.32K 10-K · filed 2022-03-29 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | $9.41K derived: sum of 4 quarters · filed 2021-03-30 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-13 | $0.00 10-Q · filed 2020-08-13 | $9.41K derived: sum of 3 quarters · filed 2021-03-30 | $9.41K derived: sum of 4 quarters · filed 2021-03-30 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-14 | $9.41K derived: sum of 2 quarters · filed 2021-03-30 | $9.41K derived: sum of 3 quarters · filed 2021-03-30 | $9.41K derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-12-31 | $9.41K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $9.41K derived: sum of 2 quarters · filed 2021-03-30 | $9.41K derived: sum of 3 quarters · filed 2021-03-30 | $10.31K 10-K · filed 2021-03-30 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $900.00 10-Q · filed 2020-11-12 | -$1.01M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-13 | $900.00 10-Q · filed 2020-08-13 | -$1.01M derived: sum of 3 quarters · filed 2020-08-13 | -$1.01M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $900.00 10-Q · filed 2020-05-14 | -$1.01M derived: sum of 2 quarters · filed 2020-05-14 | -$1.01M derived: sum of 3 quarters · filed 2020-05-14 | -$1.01M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$1.01M derived: sum of 2 quarters · filed 2020-03-30 | -$1.01M derived: sum of 3 quarters · filed 2020-03-30 | -$1.01M 10-K · filed 2020-03-30 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-13 | $0.00 derived: sum of 2 quarters · filed 2019-11-13 | $0.00 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-13 | $0.00 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | -$66.69K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |